Research ArticleOriginal Article
Open Access

Pathological spectrum of endometrial biopsies in Saudi women with abnormal uterine bleeding

A retrospective study of 13-years

Sufia Husain, Reema S. Al Hammad, Aljawhara K. Alduhaysh, Mada M. AlBatly and Ammar Alrikabi
Saudi Medical Journal March 2021, 42 (3) 270-279; DOI: https://doi.org/10.15537/smj.2021.42.3.20200814

References

  1. 1.↵
    1. Goldstein SR,
    2. Lumsden MA.
    Abnormal uterine bleeding in perimenopause. Climacteric 2017; 20: 414–420.
    OpenUrl
  2. 2.↵
    1. Deneris A.
    PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health 2016; 61: 376–379.
    OpenUrl
  3. 3.↵
    1. Setiawan VW,
    2. Yang HP,
    3. Pike MC,
    4. McCann SE,
    5. Yu H,
    6. Xiang YB, et al.
    Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013; 31: 2607–2618.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Hüsing A,
    2. Dossus L,
    3. Ferrari P,
    4. Tjønneland A,
    5. Hansen L,
    6. Fagherazzi G, et al.
    An epidemiological model for prediction of endometrial cancer risk in Europe. Eur J Epidemiol 2016; 31: 51–60.
    OpenUrlPubMed
  5. 5.↵
    1. Kaunitz AM.
    Abnormal uterine bleeding in reproductive-age women. JAMA 2019; 321: 2126–2127.
    OpenUrl
  6. 6.↵
    1. Wouk N,
    2. Helton M.
    Abnormal Uterine Bleeding in Premenopausal Women. Am Fam Physician 2019; 99: 435–443.
    OpenUrl
  7. 7.↵
    1. Hanegem VN,
    2. Prins MM,
    3. Bongers MY,
    4. Opmeer BC,
    5. Sahota DS,
    6. Mol BW, et al.
    The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016; 197: 147–155.
    OpenUrl
  8. 8.↵
    1. Bas¸aranoglu S,
    2. Agac¸ayak E,
    3. Hatırnaz S, et al.
    The diagnostic accuracy of endometrial sampling in endometrial hyperplasia. Gynecol Obstet Reprod Med 2017; 23: 37e40.
    OpenUrl
  9. 9.↵
    Practice Bulletin No. 149: Endometrial cancer. Obstet Gynecol 2015; 125: 1006–10026.
    OpenUrlPubMed
  10. 10.↵
    National Cancer Institute Surveillance, Epidemiology, and End Results Program. Cancer stat facts: uterine cancer. [cited 202 November 11]. Available from: https://seer.cancer.gov/statfacts/html/corp.html
  11. 11.↵
    1. Sun Y,
    2. Wang Y,
    3. Mao L,
    4. Wen J,
    5. Bai W.
    Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study. Medicine (Baltimore) 2018; 97: e11457.
    OpenUrl
  12. 12.↵
    1. Whitaker L,
    2. Critchley HO.
    Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2016; 34: 54–65.
    OpenUrl
  13. 13.↵
    1. Clarke MA,
    2. Long BJ,
    3. Del Mar Morillo A,
    4. Arbyn M,
    5. Bakkum-Gamez JN,
    6. Wentzensen N.
    Association of endometrial cancer risk with postmenopausal bleeding in women: A systematic review and meta-analysis. JAMA Intern Med 2018; 178: 1210–1222.
    OpenUrl
  14. 14.↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA,
    6. Jemal A.
    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. de Haydu C,
    2. Black JD,
    3. Schwab CL,
    4. English DP,
    5. Santin AD.
    An update on the current pharmacotherapy for endometrial cancer. Expert Opin Pharmacother 2016; 17: 489–499.
    OpenUrl
  16. 16.↵
    1. Kurman RJ,
    2. Ellenson LH,
    3. Ronnett BM
    1. Ellenson LH,
    2. Ronnett BM,
    3. Kurman RJ.
    Precursor of Endometrial Carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. 7th edition. Switzerland (SW): Springer Nature Switzerland AG; 2019. p. 440–458.
  17. 17.↵
    1. Giannella L,
    2. Delli Carpini G,
    3. Sopracordevole F,
    4. Papiccio M,
    5. Serri M,
    6. Giorda G, et al.
    Atypical endometrial hyperplasia and unexpected cancers at final histology: A study on endometrial sampling methods and risk factors. Diagnostics (Basel) 2020; 10: 474.
    OpenUrl
  18. 18.↵
    1. Vetter MH,
    2. Smith B,
    3. Benedict J,
    4. Hade EM,
    5. Bixel K,
    6. Copeland LJ, et al.
    Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia. Am J Obstet Gynecol 2020; 222: 60.e1–60.e7.
  19. 19.↵
    1. Amant F,
    2. Mirza MR,
    3. Koskas M,
    4. Creutzberg CL.
    Cancer of the corpus uteri. Int J Gynaecol Obstet 2018; 143 Suppl 2: 37–50.
    OpenUrl
  20. 20.↵
    1. Braun MM,
    2. Overbeek-Wager EA,
    3. Grumbo RJ.
    Diagnosis and Management of Endometrial Cancer. Am Fam Physician 2016; 93: 468–474.
    OpenUrl
  21. 21.↵
    Committee on Practice Bulletins-Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol 2013; 122: 176–185.
    OpenUrlPubMed
  22. 22.↵
    1. Giannella L,
    2. Delli Carpini G,
    3. Di Giuseppe J,
    4. Tsiroglou D,
    5. Papiccio M,
    6. Montanari M, et al.
    Atrophic endometrium in postmenopausal women referred to diagnostic hysteroscopy: a study to avoid unnecessary examinations. Eur Rev Med Pharmacol Sci 2020; 24: 5217–5222.
    OpenUrl
  23. 23.↵
    1. Elkholi DGE,
    2. Nagy HM.
    Unexplained postmenopausal uterine bleeding from atrophic endometrium: Histopathological and hormonal studies. Middle East Fertility Society Journal 2015; 20: 262–270. Doi: 10.1016/j.mefs.2015.04.005.
    OpenUrlCrossRef
  24. 24.↵
    1. Otify M,
    2. Fuller J,
    3. Ross J,
    4. Shaikh H,
    5. Johns J.
    Endometrial pathology in the postmenopausal woman-an evidence based approach to management. The Obstetrician & Gynaecologist 2015; 17: 29–38.
    OpenUrlCrossRef
  25. 25.↵
    1. Kolhe S.
    Management of abnormal uterine bleeding - focus on ambulatory hysteroscopy. Int J Womens Health 2018; 10: 127–136.
    OpenUrl
  26. 26.↵
    1. Nijkang NP,
    2. Anderson L,
    3. Markham R,
    4. Manconi F.
    Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med 2019; 7: 2050312119848247.
    OpenUrl
  27. 27.↵
    1. Kurman RJ,
    2. Ellenson LH,
    3. Ronnett BM
    1. Lastra RR,
    2. McCluggage WG and
    3. Ellenson LH.
    Benign diseases of the endometrium. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. 7th edition. Switzerland (SW). Springer Nature Switzerland AG; 2019. p. 404–405.
  28. 28.↵
    1. Song D,
    2. Feng X,
    3. Zhang Q,
    4. Xia E,
    5. Xiao Y,
    6. Xie W, et al.
    Prevalence and confounders of chronic endometritis in premenopausal women with abnormal bleeding or reproductive failure. Reprod Biomed Online 2018; 36: 78–83.
    OpenUrl
  29. 29.↵
    1. Park HJ,
    2. Kim YS,
    3. Yoon TK,
    4. Lee WS.
    Chronic endometritis and infertility. Clin Exp Reprod Med 2016; 43: 185–192.
    OpenUrlCrossRef
  30. 30.↵
    1. María VAC,
    2. Jorge DG.
    Chronic endometritis: an hidden pathology. Obstet Gynecol Int J 2020; 11: 155–156.
    OpenUrl
  31. 31.↵
    1. Liu Y,
    2. Chen X,
    3. Huang J,
    4. Wang CC,
    5. Yu MY,
    6. Laird S, et al.
    Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril 2018; 109: 832–839.
    OpenUrl
  32. 32.↵
    1. Cicinelli E,
    2. Bettocchi S,
    3. de Ziegler D,
    4. Loizzi V,
    5. Cormio G,
    6. Marinaccio M, et al.
    Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. J Minim Invasive Gynecol 2019; 26: 1346–1350.
    OpenUrl
  33. 33.↵
    1. Maybin JA,
    2. Critchley HO.
    Medical management of heavy menstrual bleeding. Womens Health (Lond) 2016; 12: 27–34.
    OpenUrl
  34. 34.↵
    1. Colombo N,
    2. Creutzberg C,
    3. Amant F,
    4. Bosse T,
    5. González-Martín A,
    6. Ledermann J, et al.
    ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 2016; 27: 16–41.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Garg K,
    2. Soslow RA.
    Endometrial carcinoma in women aged 40 years and younger. Arch Pathol Lab Med 2014; 138: 335–342.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Giannella L,
    2. Mfuta K,
    3. Setti T,
    4. Cerami LB,
    5. Bergamini E,
    6. Boselli F.
    A risk-scoring model for the prediction of endometrial cancer among symptomatic postmenopausal women with endometrial thickness > 4 mm. Biomed Res Int 2014; 2014: 130569.
    OpenUrl
  37. 37.↵
    1. Pennant ME,
    2. Mehta R,
    3. Moody P,
    4. Hackett G,
    5. Prentice A,
    6. Sharp SJ, et al.
    Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG 2017; 124: 404–411.
    OpenUrl
  38. 38.↵
    1. Giannella L,
    2. Cerami LB,
    3. Setti T,
    4. Bergamini E,
    5. Boselli F.
    Prediction of endometrial hyperplasia and cancer among premenopausal women with abnormal uterine bleeding. Biomed Res Int 2019; 2019: 8598152.
    OpenUrl
  39. 39.↵
    1. Harmanli OH,
    2. Shunmugham S,
    3. Shen T,
    4. Houck KL,
    5. Chatwani AJ.
    The negative predictive value of “inadequate” endometrial biopsy in diagnosing endometrial neoplasia. J Gynecol Surg 2004; 20: 13–16.
    OpenUrl
  40. 40.↵
    1. Giannella L,
    2. Mfuta K,
    3. Setti T,
    4. Boselli F,
    5. Bergamini E,
    6. Cerami LB.
    Diagnostic accuracy of endometrial thickness for the detection of intra-uterine pathologies and appropriateness of performed hysteroscopies among asymptomatic postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2014; 177: 29–33.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords